
Indoco Remedies Limited has informed the Exchange regarding a press release dated October 04, 2024, titled "Indoco Remedies receives final ANDA approval from the USFDA for Cetirizine Hydrochloride Tablets USP, 10 mg (OTC)".
Filed with NSE ·

Indoco Remedies Limited has informed the Exchange regarding a press release dated October 04, 2024, titled "Indoco Remedies receives final ANDA approval from the USFDA for Cetirizine Hydrochloride Tablets USP, 10 mg (OTC)".
6ix hasn’t read this filing yet.
Indoco Remedies Limited on 6ix
Follow Indoco Remedies into a list and get an email when it puts out news.
Follow Indoco Remedies